4. DESARROLLO DE
ICC EN HTA:
Bibbins-Domingo K, Pletcher MJ, Lin F, et al: Racial differences in
incident heart failure among young adults. N Engl J Med 360:1179,
4
13. CONSENSUS: COOPERATIVE NORTH SCANDINAVIAN ENALAPRIL
SURVIVAL STUDY
- NYHA IV -
Months after randomization
Probability
0 2 4
126
127
78
98
59
82
47
73
34
59
24
42
17
26
Placebo:
Enalapril:
6 8 10 12
0.2
0.0
0.6
0.4
0.8
Cumulative probability of death
Placebo
Enalapril
CONSENSUS Trial Study Group. N Engl J Med 1987;316:1429–35.
27% de reducción del RR para muerte cardiovascular
13